etoposide has been researched along with Gangliocytoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brentrup, A; Frühwald, MC; Hasselblatt, M; Holling, M; Jeibmann, A; Niederstadt, T; Paulus, W; Pfister, S; Sträter, R | 1 |
| Azuhata, T; Griffith, TS; Miller, M; Sandler, AD; Scott, D | 1 |
| Kamble, R; Raina, V; Sharma, S; Singh, SP; Tanwar, R | 1 |
| Mineta, H; Miura, K; Tsutsui, Y; Yokota, N | 1 |
4 other study(ies) available for etoposide and Gangliocytoma
| Article | Year |
|---|---|
From glioblastoma to gangliocytoma: an unforeseen but welcome shift in biological behavior.
Topics: Antigens, Nuclear; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carboplatin; Cell Differentiation; Cell Proliferation; Etoposide; Female; Ganglioneuroma; Glioblastoma; Humans; Hydrocephalus; Infant; Nerve Tissue Proteins; Neurofilament Proteins; Neurosurgical Procedures; Reverse Transcriptase Polymerase Chain Reaction; Synaptophysin | 2009 |
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Child; Etoposide; Ganglioneuroblastoma; Ganglioneuroma; GPI-Linked Proteins; Humans; Inhibitor of Apoptosis Proteins; Membrane Glycoproteins; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasm Recurrence, Local; Neuroblastoma; Predictive Value of Tests; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; Survivin; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 2006 |
Spinal ganglioneuroblastoma--complete response to chemotherapy alone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Ganglioneuroma; Humans; Ifosfamide; Male; Spinal Cord Neoplasms; Vincristine | 1993 |
Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Combined Modality Therapy; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Ganglioneuroma; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Radiotherapy, Adjuvant | 2001 |